SFV HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Second Sight’s Argus II System Receives FDA Approval

Second Sight Medical Products announced its Argus IIs Retinal Prosthesis System was approved by the U.S. Food and Drug Administration.

Amgen to Acquire Five Prime Therapeutics for $1.9 Billion

Amgen Inc. plans to acquire Bay Area biotech company Five Prime Therapeutics for $1.9 billion in cash, or $38 per share.

Lancaster, Kaiser Permanente Partner to Open Mass Vaccination Site

The City of Lancaster, in partnership with Kaiser Permanente, will open a mass vaccination site at the Antelope Valley Fairgrounds on March 8.

MannKind Convertible Notes to Raise $150 Million as Shares Fall 30 Percent

MannKind Corp. on Monday announced it intends to offer a private placement of convertible senior notes worth $150 million.

Preview: A Second Sight Buyout Strategy

Companies combine technology for visual prosthetics.

Afrezza Quarterly Sales Increase, New Therapies on Horizon at MannKind

MannKind Corp. touted increased sales for its flagship drug Afrezza during its fourth quarter earnings report, while pointing out its new direction toward therapies for lung and endocrine diseases.

Attorney, BioScience Alliance Founder Brent Reinke Switches Firms

Brent Reinke, partner at Musick Peeler Law Firm in Westlake Village, will join Stradling Yocca Carlson and Rauth as a corporate shareholder.

Tease photo

Health Net Study Looks at COVID in Communities of Color

Health Net, the medical insurer in Woodland Hills, has partnered with L.A.-based nonprofit Wesley Health Centers to conduct a study assessing the impact of the COVID-19 pandemic on racial minorities.

Lancaster Field Hospital Closes as COVID-19 Cases Decline

An emergency field hospital erected in the parking lot of Antelope Valley Hospital officially closed.

Tease photo

Arcutis Biotherapeutics Reports Operational Progress, Financial Loss in Fourth Quarter

Arcutis Biotherapeutics reported robust business progress in conjunction with its fourth-quarter earnings report.

State Investigates Whistleblower Complaints at Valencia COVID Lab

The state government is actively investigating poor management allegations at a PerkinsElmer COVID-19 testing laboratory in Valencia.

Preview: Hospitals in Distress

The struggle against COVID-19 has turned into a grim battle against exhaustion in the health care industry.

Epilepsy Care Platform Company Launches in Sherman Oaks

Digital health company Nile AI has launched in Sherman Oaks, backed by a $25 million investment by Belgian pharmaceutical company UCB.

Amgen to Sponsor BioLabs LA Program for Startups

Amgen Inc. on Wednesday announced it will sponsor BioLabs LA at the Lundquist Institute, a biotech co-working space in Torrance, via a three-year Golden Ticket program.

Amgen Beats Expectations for Fourth Quarter

Amgen Inc. beat Wall Street estimates in the fourth quarter, as sales from newer drugs such as migraine medication Aimovig offset lower revenue from older, off-patent medications.

Prev